Christopher Peetz - 10 Nov 2022 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Role
President and CEO, Director
Signature
/s/ Jody Howe, Attorney-in-Fact
Issuer symbol
MIRM
Transactions as of
10 Nov 2022
Transactions value $
$835
Form type
4
Filing time
14 Nov 2022, 20:45:08 UTC
Previous filing
12 May 2022
Next filing
05 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MIRM Common Stock Award $835 +49 +0.07% $17.05 69.6K 10 Nov 2022 Direct F1
holding MIRM Common Stock 202K 10 Nov 2022 By The Peetz Family Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4 is being filed voluntarily to report the acquisition of 49 shares by the Reporting Person on November 10, 2022 pursuant to the Issuer's Employee Stock Purchase Plan.